{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T23:17:10Z","timestamp":1768519030818,"version":"3.49.0"},"posted":{"date-parts":[[2024,10,22]]},"group-title":"Neuroscience","reference-count":72,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T00:00:00Z","timestamp":1729555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,10,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>Spinal muscular atrophy (SMA) is a neuromuscular disorder caused by reduced expression of the survival motor neuron (SMN) protein. In addition to motor neuron survival, SMN deficiency affects the integrity and function of afferent synapses that provide glutamatergic excitatory drive essential for motor neuron firing and muscle contraction. However, it is unknown whether deficits in the metabolism of excitatory amino acids and their precursors contribute to neuronal dysfunction in SMA. To address this issue, we measured the levels of the main neuroactive D- and L-amino acids acting on glutamatergic receptors in the central nervous system of SMN\u03947 mice as well as the cerebrospinal fluid (CSF) of SMA patients of varying severity before and after treatment with the SMN-inducing drug Nusinersen. Our findings reveal that SMN deficiency disrupts glutamate and serine metabolism in the CSF of severe SMA patients, including decreased concentration of L-glutamate, which is partially corrected by Nusinersen therapy. Moreover, we identify dysregulated L-glutamine to L-glutamate conversion as a shared neurochemical signature of altered glutamatergic synapse metabolism that implicates astrocyte dysfunction in both severe SMA patients and mouse models. Lastly, consistent with a correlation of higher CSF levels of D-serine with better motor function in severe SMA patients, we show that daily supplementation with the NMDA receptor co-agonist D-serine improves neurological deficits in SMN\u03947 mice. Altogether, these findings provide direct evidence for dysregulation of D- and L-amino acid metabolism linked to glutamatergic neurotransmission in severe SMA and have potential implications for treating this neurological disorder.<\/jats:p>","DOI":"10.1101\/2024.10.22.619645","type":"posted-content","created":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T20:05:51Z","timestamp":1729627551000},"source":"Crossref","is-referenced-by-count":2,"title":["Dysregulated balance of D- and L-amino acids modulating glutamatergic neurotransmission in severe spinal muscular atrophy"],"prefix":"10.64898","author":[{"given":"Amber","family":"Hassan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaella","family":"di Vito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tommaso","family":"Nuzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Vidali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Jose","family":"Carlini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shubhi","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adele","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xhesika","family":"Kolici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"Valsecchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Panicucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Pignataro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Errico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livio","family":"Pellizzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Usiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024102515301159000_2024.10.22.619645v1.1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-genom-102319-103602"},{"key":"2024102515301159000_2024.10.22.619645v1.2","doi-asserted-by":"crossref","unstructured":"Kong L , Valdivia DO , Simon CM , Hassinan CW , Delestree N , Ramos DM , et al. Impaired prenatal motor axon development necessitates early therapeutic intervention in severe SMA. Sci Transl Med. 2021;13(578).","DOI":"10.1126\/scitranslmed.abb6871"},{"key":"2024102515301159000_2024.10.22.619645v1.3","doi-asserted-by":"crossref","unstructured":"Nishio H , Niba ETE , Saito T , Okamoto K , Takeshima Y , and Awano H . Spinal Muscular Atrophy: The Past, Present, and Future of Diagnosis and Treatment. Int J Mol Sci. 2023;24(15).","DOI":"10.3390\/ijms241511939"},{"key":"2024102515301159000_2024.10.22.619645v1.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-020-00413-4"},{"key":"2024102515301159000_2024.10.22.619645v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90460-3"},{"key":"2024102515301159000_2024.10.22.619645v1.6","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0417-15.2015"},{"issue":"18","key":"2024102515301159000_2024.10.22.619645v1.7","first-page":"1723","volume":"377","year":"2017","journal-title":"Nusinersen versus sham control in infantile-onset spinal muscular atrophy"},{"issue":"4","key":"2024102515301159000_2024.10.22.619645v1.8","first-page":"306","volume":"44","year":"2021","journal-title":"Spinal muscular atrophy: in the challenge lies a solution"},{"issue":"5-6","key":"2024102515301159000_2024.10.22.619645v1.9","first-page":"180","article-title":"and","volume":"34","year":"2023","journal-title":"An overview of the therapeutic strategies for the treatment of spinal muscular atrophy"},{"issue":"1","key":"2024102515301159000_2024.10.22.619645v1.10","first-page":"1","volume":"72","year":"2021","journal-title":"Gene-targeting therapeutics for neurological disease: lessons learned from spinal muscular atrophy"},{"issue":"1","key":"2024102515301159000_2024.10.22.619645v1.11","first-page":"8","volume":"30","year":"2023","journal-title":"Curing SMA: Are we there yet"},{"key":"2024102515301159000_2024.10.22.619645v1.12","doi-asserted-by":"crossref","unstructured":"Chaytow H , Faller KM , Huang Y-T , and Gillingwater THJCRM . Spinal muscular atrophy: from approved therapies to future therapeutic targets for personalized medicine. 2021;2(7).","DOI":"10.1016\/j.xcrm.2021.100346"},{"issue":"12","key":"2024102515301159000_2024.10.22.619645v1.13","first-page":"3885","volume":"29","year":"2019","journal-title":"Stasimon contributes to the loss of sensory synapses and motor neuron death in a mouse model of spinal muscular atrophy"},{"key":"2024102515301159000_2024.10.22.619645v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2010.12.032"},{"key":"2024102515301159000_2024.10.22.619645v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.09.011"},{"key":"2024102515301159000_2024.10.22.619645v1.16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.09.012"},{"key":"2024102515301159000_2024.10.22.619645v1.17","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4561"},{"key":"2024102515301159000_2024.10.22.619645v1.18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011703"},{"key":"2024102515301159000_2024.10.22.619645v1.19","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1764-10.2010"},{"issue":"1","key":"2024102515301159000_2024.10.22.619645v1.20","first-page":"1155","volume":"6","year":"2023","journal-title":"SMN deficiency perturbs monoamine neurotransmitter metabolism in spinal muscular atrophy"},{"key":"2024102515301159000_2024.10.22.619645v1.21","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awad221"},{"key":"2024102515301159000_2024.10.22.619645v1.22","first-page":"120","volume":"622","year":"2023","journal-title":"Specialized astrocytes mediate glutamatergic gliotransmission in the CNS"},{"key":"2024102515301159000_2024.10.22.619645v1.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.conb.2007.02.006"},{"key":"2024102515301159000_2024.10.22.619645v1.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2007.03.002"},{"key":"2024102515301159000_2024.10.22.619645v1.25","doi-asserted-by":"publisher","DOI":"10.1124\/pr.109.002451"},{"issue":"7083","key":"2024102515301159000_2024.10.22.619645v1.26","first-page":"456","volume":"440","year":"2006","journal-title":"Glutamate receptors at atomic resolution"},{"issue":"3","key":"2024102515301159000_2024.10.22.619645v1.27","first-page":"282","volume":"15","year":"2005","journal-title":"Glutamate receptor ion channels"},{"issue":"5","key":"2024102515301159000_2024.10.22.619645v1.28","first-page":"1311","volume":"71","year":"2023","journal-title":"Ebert ADJG. Diminished motor neuron activity driven by abnormal astrocytic EAAT1 glutamate transporter activity in spinal muscular atrophy is not fully restored after lentiviral SMN delivery"},{"issue":"2","key":"2024102515301159000_2024.10.22.619645v1.29","first-page":"181","volume":"20","year":"2024","journal-title":"Effect of chronic maternal L-Glu intake during gestation and\/or lactation on oxidative stress markers, AMPA Glu1 receptor and adenosine A1 signalling pathway from foetal and neonatal cerebellum"},{"issue":"1","key":"2024102515301159000_2024.10.22.619645v1.30","first-page":"7","article-title":"The glutamate receptor ion channels","volume":"51","year":"1999","journal-title":"Pharmacological reviews"},{"issue":"3","key":"2024102515301159000_2024.10.22.619645v1.31","first-page":"1264","volume":"27","year":"2013","journal-title":"Vesicular uptake and exocytosis of L-aspartate is independent of sialin"},{"issue":"10","key":"2024102515301159000_2024.10.22.619645v1.32","first-page":"140471","article-title":"Usiello AJBeBA-P, and Proteomics","volume":"1868","year":"2020","journal-title":"New insights on the influence of free d-aspartate metabolism in the mammalian brain during prenatal and postnatal life"},{"issue":"4","key":"2024102515301159000_2024.10.22.619645v1.33","first-page":"162","volume":"2","year":"2015","journal-title":"Diagnostic tests: how to estimate the positive predictive value"},{"key":"2024102515301159000_2024.10.22.619645v1.34","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-020-03014-1"},{"key":"2024102515301159000_2024.10.22.619645v1.35","unstructured":"de Oliveira Souza IN , Roychaudhuri R , de Belleroche J , and Mothet J-PJTiMM . d-Amino acids: new clinical pathways for brain diseases. 2023."},{"issue":"1","key":"2024102515301159000_2024.10.22.619645v1.36","first-page":"198","article-title":"Shi LJSt, and therapy t","volume":"8","year":"2023","journal-title":"Angiogenic signaling pathways and anti-angiogenic therapy for cancer"},{"issue":"5","key":"2024102515301159000_2024.10.22.619645v1.37","first-page":"767","volume":"29","year":"2005","journal-title":"Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients"},{"key":"2024102515301159000_2024.10.22.619645v1.38","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2015.61"},{"issue":"10","key":"2024102515301159000_2024.10.22.619645v1.39","first-page":"1431","volume":"12","year":"2022","journal-title":"Nusinersen induces disease-severity-specific neurometabolic effects in spinal muscular atrophy"},{"key":"2024102515301159000_2024.10.22.619645v1.40","doi-asserted-by":"crossref","unstructured":"Buettner JM , Longang JKS , Gerstner F , Apel KS , Blanco-Redondo B , Sowoidnich L , et al. Central synaptopathy is the most conserved feature of motor circuit pathology across spinal muscular atrophy mouse models. 2021;24(11).","DOI":"10.1016\/j.isci.2021.103376"},{"issue":"3","key":"2024102515301159000_2024.10.22.619645v1.41","first-page":"558","volume":"11","year":"2022","journal-title":"Induction of survival of motor neuron (SMN) protein deficiency in spinal astrocytes by small interfering RNA as an in vitro model of spinal muscular atrophy"},{"issue":"22","key":"2024102515301159000_2024.10.22.619645v1.42","first-page":"5671","volume":"20","year":"2019","journal-title":"Excitatory amino acid transporters in physiology and disorders of the central nervous system"},{"issue":"18","key":"2024102515301159000_2024.10.22.619645v1.43","first-page":"10878","article-title":"and","volume":"23","year":"2022","journal-title":"Mitochondrial dysfunction in spinal muscular atrophy"},{"key":"2024102515301159000_2024.10.22.619645v1.44","doi-asserted-by":"crossref","unstructured":"Abati E , Citterio G , Bresolin N , Comi GP , and Corti SJNod . Glial cells involvement in spinal muscular atrophy: Could SMA be a neuroinflammatory disease? 2020;140:104870.","DOI":"10.1016\/j.nbd.2020.104870"},{"issue":"21","key":"2024102515301159000_2024.10.22.619645v1.45","first-page":"5309","volume":"37","year":"2017","journal-title":"Decreased motor neuron support by SMA astrocytes due to diminished MCP1 secretion"},{"issue":"1","key":"2024102515301159000_2024.10.22.619645v1.46","first-page":"3701","volume":"9","year":"2019","journal-title":"Notch signaling mediates astrocyte abnormality in spinal muscular atrophy model systems"},{"issue":"14","key":"2024102515301159000_2024.10.22.619645v1.47","first-page":"4094","volume":"24","year":"2015","journal-title":"Astrocytes influence the severity of spinal muscular atrophy"},{"issue":"24","key":"2024102515301159000_2024.10.22.619645v1.48","first-page":"5131","article-title":"and Sciences ML","volume":"77","year":"2020","journal-title":"L-serine synthesis via the phosphorylated pathway in humans"},{"issue":"6","key":"2024102515301159000_2024.10.22.619645v1.49","first-page":"1546","volume":"41","year":"2013","journal-title":"The serine shuttle between glia and neurons: implications for neurotransmission and neurodegeneration"},{"key":"2024102515301159000_2024.10.22.619645v1.50","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20977"},{"issue":"9","key":"2024102515301159000_2024.10.22.619645v1.51","first-page":"1580","volume":"7","year":"2020","journal-title":"Widespread tissue hypoxia dysregulates cell and metabolic pathways in SMA"},{"key":"2024102515301159000_2024.10.22.619645v1.52","first-page":"226","volume":"31","year":"2018","journal-title":"Interventions targeting glucocorticoid-Kr\u00fcppel-like factor 15-branched-chain amino acid signaling improve disease phenotypes in spinal muscular atrophy mice"},{"key":"2024102515301159000_2024.10.22.619645v1.53","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-013-9592-4"},{"key":"2024102515301159000_2024.10.22.619645v1.54","doi-asserted-by":"publisher","DOI":"10.1172\/JCI57549"},{"key":"2024102515301159000_2024.10.22.619645v1.55","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2016.1221971"},{"issue":"18","key":"2024102515301159000_2024.10.22.619645v1.56","first-page":"4149","volume":"26","year":"2007","journal-title":"d-Serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis"},{"issue":"43","key":"2024102515301159000_2024.10.22.619645v1.57","first-page":"17844","volume":"108","year":"2011","journal-title":"Phosphorylation of a mitotic kinesin-like protein and a MAPKKK by cyclin-dependent kinases (CDKs) is involved in the transition to cytokinesis in plants"},{"issue":"16","key":"2024102515301159000_2024.10.22.619645v1.58","first-page":"7556","volume":"107","year":"2010","journal-title":"Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase"},{"key":"2024102515301159000_2024.10.22.619645v1.59","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2014.05.015"},{"issue":"2","key":"2024102515301159000_2024.10.22.619645v1.60","first-page":"376","volume":"41","year":"2021","journal-title":"Chronic pharmacological increase of neuronal activity improves sensory-motor dysfunction in spinal muscular atrophy mice"},{"key":"2024102515301159000_2024.10.22.619645v1.61","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.3237-07.2008"},{"key":"2024102515301159000_2024.10.22.619645v1.62","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2728-12.2013"},{"key":"2024102515301159000_2024.10.22.619645v1.63","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25533"},{"key":"2024102515301159000_2024.10.22.619645v1.64","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000006331"},{"key":"2024102515301159000_2024.10.22.619645v1.65","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-02065-z"},{"key":"2024102515301159000_2024.10.22.619645v1.66","doi-asserted-by":"publisher","DOI":"10.3233\/JND-180301"},{"key":"2024102515301159000_2024.10.22.619645v1.67","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2009.11.014"},{"key":"2024102515301159000_2024.10.22.619645v1.68","doi-asserted-by":"publisher","DOI":"10.1097\/PEP.0b013e3182351f04"},{"key":"2024102515301159000_2024.10.22.619645v1.69","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmd.2007.05.009"},{"issue":"4","key":"2024102515301159000_2024.10.22.619645v1.70","first-page":"1154","volume":"28","year":". 2020","journal-title":"miR-206 reduces the severity of motor neuron degeneration in the facial nuclei of the brainstem in a mouse model of SMA"},{"issue":"6","key":"2024102515301159000_2024.10.22.619645v1.71","first-page":"845","volume":"14","year":"2005","journal-title":"SMN\u03947, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN"},{"key":"2024102515301159000_2024.10.22.619645v1.72","first-page":"149923","volume":"712","year":"2024","journal-title":"Stasimon\/Tmem41b is required for cell proliferation and adult mouse survival."}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.10.22.619645","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T07:18:52Z","timestamp":1768461532000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2024.10.22.619645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,22]]},"references-count":72,"URL":"https:\/\/doi.org\/10.1101\/2024.10.22.619645","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1016\/j.nbd.2025.106849","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,10,22]]},"subtype":"preprint"}}